Cathie Wood Regeneron Pharmaceuticals, Inc. Transaction History

Ark Investment Management LLC

$10.5 Billion
Q3 2024

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 15,151 shares of REGN stock, worth $11.3 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

15,151

Previous 15,865 4.5%

Holding current value

$11.3 Million

Previous $16.7 Million 4.48%

% of portfolio

0.15%

Previous 0.15%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$1024.09 - $1201.76 $731,200 - $858,056	-714 Reduced 4.5%	15,151 $15.9 Million
Q2 2024 Jul 26, 2024	SELL	$883.2 - $1071.19 $2.07 Million - $2.52 Million	-2,348 Reduced 12.89%	15,865 $16.7 Million
Q1 2024 Apr 18, 2024	SELL	$902.69 - $993.35 $8.59 Million - $9.45 Million	-9,518 Reduced 34.32%	18,213 $17.5 Million
Q4 2023 Jan 17, 2024	SELL	$775.18 - $881.7 $6,976 - $7,935	-9 Reduced 0.03%	27,731 $24.4 Million
Q3 2023 Oct 18, 2023	SELL	$692.45 - $844.37 $3.13 Million - $3.81 Million	-4,513 Reduced 13.99%	27,740 $22.8 Million
Q2 2023 Jul 10, 2023	SELL	$700.03 - $830.35 $936,640 - $1.11 Million	-1,338 Reduced 3.98%	32,253 $23.2 Million
Q1 2023 Apr 17, 2023	SELL	$680.49 - $826.97 $314,386 - $382,060	-462 Reduced 1.36%	33,591 $27.6 Million
Q4 2022 Jan 24, 2023	SELL	$705.89 - $766.39 $2.04 Million - $2.21 Million	-2,888 Reduced 7.82%	34,053 $0
Q3 2022 Oct 17, 2022	SELL	$573.97 - $724.32 $10.8 Million - $13.7 Million	-18,870 Reduced 33.81%	36,941 $25.4 Million
Q2 2022 Jul 11, 2022	SELL	$548.35 - $738.84 $1.08 Million - $1.45 Million	-1,962 Reduced 3.4%	55,811 $37.1 Million
Q1 2022 Apr 19, 2022	SELL	$595.12 - $698.43 $9.06 Million - $10.6 Million	-15,220 Reduced 20.85%	57,773 $40.4 Million
Q4 2021 Jan 28, 2022	SELL	$543.48 - $670.97 $193 Million - $238 Million	-355,154 Reduced 82.95%	72,993 $46.1 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $164 Million - $194 Million	-284,901 Reduced 39.96%	428,147 $259 Million
Q2 2021 Aug 05, 2021	SELL	$472.8 - $558.54 $239 Million - $283 Million	-505,922 Reduced 41.5%	713,048 $398 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $343 Million - $421 Million	767,152 Added 169.79%	1,218,970 $577 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $216 Million - $275 Million	451,818 New	451,818 $218 Million
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $43,905 - $57,308	-89 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$274.13 - $376.51 $11 Million - $15.1 Million	-39,984 Reduced 99.78%	89 $33,000
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $3.14 Million - $3.66 Million	11,480 Added 40.15%	40,073 $11.1 Million
Q2 2019 Jul 30, 2019	BUY	$299.6 - $414.82 $4.6 Million - $6.37 Million	15,356 Added 116.01%	28,593 $8.95 Million
Q1 2019 May 13, 2019	SELL	$372.08 - $439.57 $254,502 - $300,665	-684 Reduced 4.91%	13,237 $5.44 Million
Q4 2018 Feb 01, 2019	SELL	$335.82 - $403.04 $3.13 Million - $3.76 Million	-9,319 Reduced 40.1%	13,921 $5.2 Million
Q3 2018 Nov 07, 2018	BUY	$351.14 - $408.51 $1.64 Million - $1.9 Million	4,658 Added 25.07%	23,240 $9.39 Million
Q2 2018 Aug 07, 2018	BUY	$284.6 - $344.99 $4.34 Million - $5.26 Million	15,257 Added 458.86%	18,582 $6.41 Million
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $178,122 - $222,091	564 Added 20.43%	3,325 $1.15 Million
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $190,073 - $249,073	530 Added 23.76%	2,761 $1.04 Million
Q3 2017 Nov 09, 2017	BUY	$431.38 - $504.0 $430,085 - $502,488	997 Added 80.79%	2,231 $998,000
Q2 2017 Aug 11, 2017	BUY	N/A	544 Added 78.84%	1,234 $606,000
Q1 2017 May 15, 2017	BUY	N/A	68 Added 10.93%	690 $267,000
Q4 2016 Feb 13, 2017	BUY	N/A	622	622 $228,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account